NIA
VRTX icon

NIA Impact Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

NIA Impact Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.28M Sell
14,663
-827
-5% -$367K 3.02% 7
2026
Q1 		$6.92M Sell
15,490
-2,148
-12% -$1M 3.08% 7
2025
Q4 		$8M Buy
17,638
+1,705
+11% +$735K 2.68% 6
2025
Q3 		$6.24M Buy
15,933
+46
+0.3% +$19.2K 2.03% 16
2025
Q2 		$7.07M Sell
15,887
-45
-0.3% -$20.7K 2.44% 12
2025
Q1 		$7.72M Hold
15,932
– – 2.87% 5
2024
Q4 		$6.42M Sell
15,932
-1,395
-8% -$647K 2.09% 16
2024
Q3 		$8.06M Sell
17,327
-1,452
-8% -$697K 2.68% 9
2024
Q2 		$8.8M Sell
18,779
-978
-5% -$424K 3.16% 5
2024
Q1 		$8.26M Buy
+19,757
New +$8.35M 3.29% 5
2023
Q2 		$6.96M Sell
20,046
-180
-0.9% -$60.6K 3.96% 5
2023
Q1 		$6.37M Buy
20,226
+1,051
+5% +$315K 3.44% 7
2022
Q4 		$5.54M Buy
19,175
+2,023
+12% +$617K 3.22% 6
2022
Q3 		$4.97M Buy
17,152
+9,533
+125% +$2.74M 3.06% 7
2022
Q2 		$2.15M Buy
+7,619
New +$2.04M 1.29% 30

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

NIA Impact Advisors's VRTX Position: Q2 2026 in Review

NIA Impact Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 5.3% in Q2 2026, selling an estimated $367K and leaving 14,663 shares worth $7.28M. The position accounts for 3.02% of the portfolio, ranked #7.

NIA Impact Advisors first reported a position in VRTX in Q2 2022 and has held it in 15 quarters since. The position peaked at $8.8M in Q2 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • NIA Impact Advisors held 14,663 shares of Vertex Pharmaceuticals worth $7.28M as of Q2 2026.
  • NIA Impact Advisors sold 827 Vertex Pharmaceuticals shares in Q2 2026, an estimated $367K.
  • Vertex Pharmaceuticals made up 3.02% of NIA Impact Advisors's portfolio in Q2 2026, its #7 holding.
  • NIA Impact Advisors first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
  • NIA Impact Advisors's Vertex Pharmaceuticals position peaked at $8.8M in Q2 2024.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on NIA Impact Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.